Dr. Aft on Disseminating Tumor Cells and Prognosis
June 14th 2013Rebecca L. Aft, MD, PhD, discusses the identification of patients with breast cancer at high risk of recurrent disease development by detection of HER2-positive disseminated tumor cells in bone marrow of patients with HER2-negative tumors.
Read More